Welcome to the latest edition of touchREVIEWS in Ophthalmology, which includes a range of editorial and review articles on a variety of insightful topics within the ophthalmology landscape including macular degeneration, ocular surface disease and imaging. We are also pleased to introduce the new Editor-in-Chief, Jennifer Loh, MD.
We hope you enjoy this selection of timely and informative articles. We would like to thank all our contributors and reviewers, and of course our Editorial Board members, who provide unfailing support and insight.
Foreword: touchREVIEWS in Ophthalmology, Volume 17, Issue 2, 2023
Welcome to the latest edition of touchREVIEWS in Ophthalmology, and my first as the journal’s Editor-in-Chief. In this issue, we are delighted to present a series of compelling articles providing insights into some of the cutting-edge developments in this diverse and ever-evolving field. Dhanashree Ratra and Aashna Ratra open the edition with the first in […]
Reinventing Treatment: Bevacizumab-vikg in the Battle Against Wet Age-related Macular Degeneration
Age-related macular degeneration (AMD) is a progressive eye condition that affects millions of people worldwide and poses a significant threat to vision in individuals over the age of 50.1 Of the two types of AMD, wet AMD, which is characterized by the growth of a choroidal neovascular membrane, is responsible for approximately 90% of the vision […]
Review of Suprachoroidal Delivery and its Application in Small Molecule Therapy
Retinal pharmacotherapy encompasses various drug delivery routes that offer potential avenues for effective treatment (Figure 1). Among these, intravitreal injections have emerged as the predominant method employed in clinical practice.1 They have established themselves as the primary approach for administering anti-vascular endothelial growth factor (anti-VEGF) therapy, serving as the frontline treatment for neovascular age-related macular degeneration […]
Artificial Intelligence for the Diagnosis and Screening of Retinal Diseases
Article highlights Artificial intelligence (AI) represents a powerful way of analysing a large amount of data, extracting those features characterizing a given disease or condition. AI-based models have been largely tested in the main retinopathies, including age-related macular degeneration, diabetic retinopathy and myopia. AI algorithms have been highly effective in screening for retinopathies. The same […]
Peering into the Dry Eye Pipeline for 2023 and Beyond
Dry eye disease (DED) is a multifactorial condition of the ocular surface and tears. It is frequently encountered in ocular practices, comprising nearly 33% of visits in the USA, and with an estimated global prevalence ranging between 5% and 50%.1,2 The chronic symptoms and discomfort reported by patients with DED directly impact their quality of life […]
Pharmacologic Mydriasis and Cycloplegia: A Review of Novel Delivery Devices
Mydriasis physiology Mydriasis refers to physiologic or pharmacologic pupillary dilation. Physiologic pupillary dilation occurs naturally as a response to low light and viewing objects in the distance. This process is mediated by both the iris sphincter and the iris dilator muscles, the latter of which contracts in response to sympathetic stimulation and relaxes in response to […]
Predictive Deep Learning Applications in Ophthalmology
The term ‘artificial intelligence’ was coined by a group of scientists during a workshop known as the “Dartmouth Summer Research Project on Artificial Intelligence” in 1956.1 The concept was based on the idea that “intelligent human behavior consisted in processes that could be formalized and reproduced in machine”.1 The subfield of machine learning (ML) aims to train […]